Published in J Thromb Thrombolysis on February 01, 2002
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90
In vivo PEG modification of vascular surfaces for targeted delivery. J Vasc Surg (2011) 0.81
Facile coupling of synthetic peptides and peptide-polymer conjugates to cartilage via transglutaminase enzyme. Biomaterials (2007) 0.81
Click hybridization of immune cells and polyamidoamine dendrimers. Adv Healthc Mater (2014) 0.81
Characterizing the modification of surface proteins with poly(ethylene glycol) to interrupt platelet adhesion. Biomaterials (2006) 0.80
Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery. Int J Nanomedicine (2010) 0.78
Targeting microspheres and cells to polyethylene glycol-modified biological surfaces. J Biomed Mater Res A (2007) 0.77
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med (1994) 9.15
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med (1997) 4.36
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet (1998) 4.03
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med (1994) 3.96
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med (1988) 1.55
Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers. Proc Natl Acad Sci U S A (1994) 1.46
Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing. Proc Natl Acad Sci U S A (1996) 1.10
Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation (1987) 1.00
Creating molecular barriers to acute platelet deposition on damaged arteries with reactive polyethylene glycol. J Biomed Mater Res (1998) 0.96
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol (1987) 0.94
Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol. Biomaterials (1998) 0.92
Role of platelets in restenosis after percutaneous coronary revascularization. J Am Coll Cardiol (1996) 0.87
Initial platelet deposition at the human microvascular anastomosis: effect on downstream platelet deposition to intact and injured vessels. Plast Reconstr Surg (1992) 0.81
NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature (2003) 5.09
Sustainability metrics: life cycle assessment and green design in polymers. Environ Sci Technol (2010) 2.77
Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine. J Biomed Mater Res (2002) 2.49
Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials (2006) 2.40
Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res (2005) 2.34
Myocardial ischemic memory imaging with molecular echocardiography. Circulation (2007) 2.13
Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications. Biomaterials (2005) 2.08
Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials (2005) 1.91
Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation (2003) 1.83
In vivo evaluation of a porous, elastic, biodegradable patch for reconstructive cardiac procedures. Ann Thorac Surg (2007) 1.72
Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res (2008) 1.62
Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials (2009) 1.62
Fabrication of biodegradable elastomeric scaffolds with sub-micron morphologies. J Biomed Mater Res A (2004) 1.61
Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng (2002) 1.59
Biodegradable poly(ether ester urethane)urea elastomers based on poly(ether ester) triblock copolymers and putrescine: synthesis, characterization and cytocompatibility. Biomaterials (2004) 1.57
Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng (2005) 1.53
Characterization of the complete fiber network topology of planar fibrous tissues and scaffolds. Biomaterials (2010) 1.51
Permanent, non-leaching antibacterial surface--2: how high density cationic surfaces kill bacterial cells. Biomaterials (2007) 1.48
Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials (2007) 1.48
An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J Am Coll Cardiol (2007) 1.44
An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc (2008) 1.43
Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization. Biomaterials (2007) 1.34
Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater (2010) 1.33
beta4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1. Mol Biol Cell (2006) 1.32
Use of cardiac CT angiography imaging in an epidemiology study - the Methodology of the Multicenter AIDS Cohort Study cardiovascular disease substudy. Anadolu Kardiyol Derg (2013) 1.31
Synthesis of uniform protein-polymer conjugates. Biomacromolecules (2005) 1.30
Synthesis, characterization and cytocompatibility of polyurethaneurea elastomers with designed elastase sensitivity. Biomacromolecules (2005) 1.26
Pericyte-based human tissue engineered vascular grafts. Biomaterials (2010) 1.25
A seeding device for tissue engineered tubular structures. Biomaterials (2006) 1.24
Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J Control Release (2007) 1.21
Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue. Circulation (2003) 1.21
A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater (2009) 1.20
Platelet activation, aggregation, and life span in calves implanted with axial flow ventricular assist devices. Ann Thorac Surg (2002) 1.19
Tissue-to-cellular level deformation coupling in cell micro-integrated elastomeric scaffolds. Biomaterials (2008) 1.18
Flow cytometric assays for quantifying activated ovine platelets. Artif Organs (2007) 1.15
In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A (2010) 1.14
Mechanical properties and in vivo behavior of a biodegradable synthetic polymer microfiber-extracellular matrix hydrogel biohybrid scaffold. Biomaterials (2011) 1.13
The engineering of organized human corneal tissue through the spatial guidance of corneal stromal stem cells. Biomaterials (2011) 1.11
Permanent, nonleaching antibacterial surfaces. 1. Synthesis by atom transfer radical polymerization. Biomacromolecules (2004) 1.10
Transient elastic support for vein grafts using a constricting microfibrillar polymer wrap. Biomaterials (2008) 1.10
Predicting membrane oxygenator pressure drop using computational fluid dynamics. Artif Organs (2002) 1.09
Biocompatibility assessment of the first generation PediaFlow pediatric ventricular assist device. Artif Organs (2011) 1.08
Elimination of adverse leakage flow in a miniature pediatric centrifugal blood pump by computational fluid dynamics-based design optimization. ASAIO J (2005) 1.08
Matrix metalloproteinase-1 treatment of muscle fibrosis. Acta Biomater (2008) 1.07
Hybrid nanofibrous scaffolds from electrospinning of a synthetic biodegradable elastomer and urinary bladder matrix. J Biomater Sci Polym Ed (2008) 1.07
Synthesis of biocompatible segmented polyurethanes from aliphatic diisocyanates and diurea diol chain extenders. Acta Biomater (2005) 1.05
A small diameter, fibrous vascular conduit generated from a poly(ester urethane)urea and phospholipid polymer blend. Biomaterials (2009) 1.05
Calcium alginate microencapsulation of ovarian follicles impacts FSH delivery and follicle morphology. Reprod Biol Endocrinol (2005) 1.05
Matrix metalloproteinase-1 therapy improves muscle healing. J Appl Physiol (1985) (2007) 1.04
Morphological and mechanical characteristics of the reconstructed rat abdominal wall following use of a wet electrospun biodegradable polyurethane elastomer scaffold. Biomaterials (2010) 1.04
On the biomechanical function of scaffolds for engineering load-bearing soft tissues. Acta Biomater (2010) 1.04
Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation. J Biomed Mater Res A (2007) 1.03
Bioengineering organized, multilamellar human corneal stromal tissue by growth factor supplementation on highly aligned synthetic substrates. Tissue Eng Part A (2013) 1.02
Decontamination of chemical and biological warfare agents with a single multi-functional material. Biomaterials (2010) 1.02
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2012) 1.00
Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability. Biomacromolecules (2010) 1.00
Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers. Acta Biomater (2009) 0.99
Covalent surface modification of a titanium alloy with a phosphorylcholine-containing copolymer for reduced thrombogenicity in cardiovascular devices. J Biomed Mater Res A (2009) 0.99
Protein-reactive, thermoresponsive copolymers with high flexibility and biodegradability. Biomacromolecules (2008) 0.99
Elastomeric electrospun polyurethane scaffolds: the interrelationship between fabrication conditions, fiber topology, and mechanical properties. Adv Mater (2011) 0.98
Fiber micro-architecture in the longitudinal-radial and circumferential-radial planes of ascending thoracic aortic aneurysm media. J Biomech (2013) 0.98
Impact of ionic liquid physical properties on lipase activity and stability. J Am Chem Soc (2003) 0.97
Tailoring the degradation kinetics of poly(ester carbonate urethane)urea thermoplastic elastomers for tissue engineering scaffolds. Biomaterials (2010) 0.97
Generating elastic, biodegradable polyurethane/poly(lactide-co-glycolide) fibrous sheets with controlled antibiotic release via two-stream electrospinning. Biomacromolecules (2008) 0.97
Synthesis, characterization and surface modification of low moduli poly(ether carbonate urethane)ureas for soft tissue engineering. Acta Biomater (2009) 0.96
Ultrasound molecular imaging of cardiovascular disease. Nat Clin Pract Cardiovasc Med (2008) 0.96
The aortic root: comparison of measurements from ECG-gated CT angiography with transthoracic echocardiography. J Thorac Imaging (2009) 0.95
Right ventricular outflow tract repair with a cardiac biologic scaffold. Cells Tissues Organs (2011) 0.95
Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis. Tissue Eng Part A (2011) 0.95
Inductive, scaffold-based, regenerative medicine approach to reconstruction of the temporomandibular joint disk. J Oral Maxillofac Surg (2012) 0.94
Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function. Tissue Eng Part A (2011) 0.94
Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. Biomaterials (2010) 0.94
Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice. J Vasc Surg (2011) 0.94
Microstructural manipulation of electrospun scaffolds for specific bending stiffness for heart valve tissue engineering. Acta Biomater (2012) 0.93
Towards microfabricated biohybrid artificial lung modules for chronic respiratory support. Biomed Microdevices (2009) 0.93
Nonleaching antibacterial glass surfaces via "Grafting Onto": the effect of the number of quaternary ammonium groups on biocidal activity. Langmuir (2008) 0.93
Towards improved artificial lungs through biocatalysis. Biomaterials (2007) 0.93
Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients. Circ Cardiovasc Imaging (2013) 0.93
Synthesis, biodegradability, and biocompatibility of lysine diisocyanate-glucose polymers. Tissue Eng (2002) 0.92
In Vitro and In Vivo Performance Evaluation of the Second Developmental Version of the PediaFlow Pediatric Ventricular Assist Device. Cardiovasc Eng Technol (2011) 0.92
Scale-dependent fiber kinematics of elastomeric electrospun scaffolds for soft tissue engineering. J Biomed Mater Res A (2010) 0.92
Mechano-growth factor peptide, the COOH terminus of unprocessed insulin-like growth factor 1, has no apparent effect on myoblasts or primary muscle stem cells. Am J Physiol Endocrinol Metab (2013) 0.92
In vivo performance of a phospholipid-coated bioerodable elastomeric graft for small-diameter vascular applications. J Biomed Mater Res A (2010) 0.92
Current and future considerations in the use of mechanical circulatory support devices. Annu Rev Biomed Eng (2008) 0.91
Assessment of hydraulic performance and biocompatibility of a MagLev centrifugal pump system designed for pediatric cardiac or cardiopulmonary support. ASAIO J (2007) 0.91
Targeted ultrasound imaging using microbubbles. Cardiol Clin (2004) 0.91
Biodegradable polyurethane ureas with variable polyester or polycarbonate soft segments: effects of crystallinity, molecular weight, and composition on mechanical properties. Biomacromolecules (2011) 0.91
Non-invasive characterization of polyurethane-based tissue constructs in a rat abdominal repair model using high frequency ultrasound elasticity imaging. Biomaterials (2013) 0.90
Antimicrobial activities of silver used as a polymerization catalyst for a wound-healing matrix. Biomaterials (2006) 0.89
Prevention of seroma formation with TissuGlu® surgical adhesive in a canine abdominoplasty model: long term clinical and histologic studies. J Plast Reconstr Aesthet Surg (2012) 0.89
A biodegradable polyurethane-ascorbic acid scaffold for bone tissue engineering. J Biomed Mater Res A (2003) 0.89
Extended and sequential delivery of protein from injectable thermoresponsive hydrogels. J Biomed Mater Res A (2012) 0.89
Maintenance of morphology and growth of ovarian follicles in suspension culture. Tissue Eng (2004) 0.89
Controlled release of IGF-1 and HGF from a biodegradable polyurethane scaffold. Pharm Res (2011) 0.89
Antibacterial polypropylene via surface-initiated atom transfer radical polymerization. Biomacromolecules (2007) 0.88
Acute in vivo testing of a respiratory assist catheter: implants in calves versus sheep. ASAIO J (2003) 0.87
Placement of an elastic biodegradable cardiac patch on a subacute infarcted heart leads to cellularization with early developmental cardiomyocyte characteristics. J Card Fail (2012) 0.87
Simple surface modification of a titanium alloy with silanated zwitterionic phosphorylcholine or sulfobetaine modifiers to reduce thrombogenicity. Colloids Surf B Biointerfaces (2010) 0.87